T. Rowe Price Associates’s Tourmaline Bio TRML Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$173K	Buy	10,761 +518	+5%	+$8.33K	﹤0.01%	2763
2025 Q1	$156K	Buy	+10,243	New	+$156K	﹤0.01%	2720
2024 Q4	–	Sell	-7,753	Closed	-$200K	–	3051
2024 Q3	$200K	Buy	+7,753	New	+$200K	﹤0.01%	2654